Kidney Transplant Rejection
📧 Sign up to get email alerts when something new happens for Kidney Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-01-06FDA Approved: ENVARSUS XR — Supplemental Application (Veloxis Pharmaceuticals, Inc)
FDA processed a supplemental approval for ENVARSUS XR (tacrolimus) from Veloxis Pharmaceuticals, potentially expanding its labeling or indic…
-
FDA approval · 2016-10-28FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Endo USA, Inc.)
FDA approves Endo USA, Inc.'s generic mycophenolate mofetil original application (ANDA 203575), enabling its use to prevent organ transplant…
-
FDA approval · 2016-08-01FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Mycophenolate mofetil from Strides Pharma Science Limited under an ANDA.
-
FDA approval · 2016-08-01FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for the generic drug Mycophenolate mofetil from Strides Pharma Science Limited, finalizing changes t…
-
FDA approval · 2016-06-22FDA Approved: ENVARSUS XR — Supplemental Application (Veloxis Pharmaceuticals, Inc)
The FDA approved a supplemental application for ENVARSUS XR (tacrolimus) submitted by Veloxis Pharmaceuticals, Inc., adding/updating its ind…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-06-07FDA Approved: ENVARSUS XR — Supplemental Application (Veloxis Pharmaceuticals, Inc)
The FDA approved a supplemental application for ENVARSUS XR (tacrolimus) submitted by Veloxis Pharmaceuticals, Inc. The approval is for the …
-
FDA approval · 2016-05-26FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil) submitted by Genentech, Inc. The action authorizes changes unde…
-
FDA approval · 2016-01-22FDA Approved: TACROLIMUS — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for tacrolimus from Strides Pharma Science Limited.
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for Accord Healthcare's mycophenolate mofetil, a generic immunosuppressant, to support its use i…
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for mycophenolate mofetil submitted by Ascend Laboratories, LLC.
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for mycophenolate mofetil from Ascend Laboratories, LLC.
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application to allow Strides Pharma Science Limited to market a generic mycophenolate mofetil. This approval…
-
FDA approval · 2015-11-09FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for mycophenolate mofetil from Sandoz Inc under an ANDA, authorizing changes to the product labeling…
-
FDA approval · 2015-11-06FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's supplemental application for mycophenolate mofetil (generic) under an existing ANDA.
-
FDA approval · 2015-10-30FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for mycophenolate mofetil, enabling generic manufacturing and marketi…
-
FDA approval · 2015-10-30FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for mycophenolate mofetil filed by Mylan Pharmaceuticals Inc. The action relates to the approved gen…
-
FDA approval · 2015-10-13FDA Approved: TACROLIMUS — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for tacrolimus from Quallent Pharmaceuticals Health LLC, approving a generic formulation for use in …
-
FDA approval · 2015-08-12FDA Approved: ENVARSUS XR — Supplemental Application (Veloxis Pharmaceuticals, Inc)
The FDA approved a supplemental application for ENVARSUS XR (tacrolimus) filed by Veloxis Pharmaceuticals, authorizing changes to the NDA vi…
-
FDA approval · 2015-07-09FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil hydrochloride) submitted by Genentech, Inc.
-
FDA approval · 2015-07-09FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CellCept (mycophenolate mofetil) submitted by Genentech, Inc.
-
FDA approval · 2014-11-14FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Ascend Laboratories, LLC)
FDA approved an original application for a generic version of mycophenolate mofetil from Ascend Laboratories, intended to prevent organ tran…
-
FDA approval · 2014-10-27FDA Approved: SIROLIMUS — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories' original application for a generic sirolimus product, enabling its use as an immunosuppressant for tr…
-
FDA approval · 2014-06-26FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for mycophenolic acid from Apotex Corp.
-
FDA approval · 2014-04-15FDA Approved: NULOJIX — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approves a supplemental application for NULOJIX (belatacept) from E.R. Squibb & Sons, L.L.C., under BLA125288.
-
FDA approval · 2014-02-27FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)
The FDA approved a supplemental application for tacrolimus from Sandoz Inc., a generic immunosuppressant used to prevent organ rejection in …